nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—CYP2D6—breast cancer	0.13	0.384	CbGaD
Cephalexin—SLC47A1—Mitoxantrone—breast cancer	0.118	0.291	CbGbCtD
Cephalexin—CYP3A4—breast cancer	0.112	0.329	CbGaD
Cephalexin—ALB—breast cancer	0.0973	0.287	CbGaD
Cephalexin—CYP3A4—Exemestane—breast cancer	0.0236	0.0581	CbGbCtD
Cephalexin—CYP2D6—Idarubicin—breast cancer	0.0214	0.0525	CbGbCtD
Cephalexin—CYP3A4—Letrozole—breast cancer	0.0201	0.0494	CbGbCtD
Cephalexin—CYP3A4—Anastrozole—breast cancer	0.0179	0.0441	CbGbCtD
Cephalexin—CYP3A4—Toremifene—breast cancer	0.0164	0.0403	CbGbCtD
Cephalexin—CYP3A4—Fulvestrant—breast cancer	0.0152	0.0375	CbGbCtD
Cephalexin—ALB—Irinotecan—breast cancer	0.0147	0.0361	CbGbCtD
Cephalexin—ALB—Fluorouracil—breast cancer	0.0141	0.0346	CbGbCtD
Cephalexin—CYP3A4—Thiotepa—breast cancer	0.0136	0.0334	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—breast cancer	0.0131	0.0322	CbGbCtD
Cephalexin—CYP3A4—Ixabepilone—breast cancer	0.0124	0.0305	CbGbCtD
Cephalexin—CYP3A4—Lapatinib—breast cancer	0.012	0.0294	CbGbCtD
Cephalexin—CYP2D6—Vinorelbine—breast cancer	0.0104	0.0256	CbGbCtD
Cephalexin—CYP2D6—Tamoxifen—breast cancer	0.00942	0.0232	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—breast cancer	0.00912	0.0224	CbGbCtD
Cephalexin—CYP3A4—Raloxifene—breast cancer	0.00906	0.0223	CbGbCtD
Cephalexin—ALB—Methotrexate—breast cancer	0.00776	0.0191	CbGbCtD
Cephalexin—CYP3A4—Vinorelbine—breast cancer	0.00663	0.0163	CbGbCtD
Cephalexin—CYP2D6—Vinblastine—breast cancer	0.00643	0.0158	CbGbCtD
Cephalexin—CYP3A4—Tamoxifen—breast cancer	0.00599	0.0147	CbGbCtD
Cephalexin—CYP3A4—Mitoxantrone—breast cancer	0.00584	0.0144	CbGbCtD
Cephalexin—CYP3A4—Paclitaxel—breast cancer	0.00466	0.0115	CbGbCtD
Cephalexin—CYP3A4—Irinotecan—breast cancer	0.0046	0.0113	CbGbCtD
Cephalexin—CYP3A4—Vinblastine—breast cancer	0.00409	0.0101	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—breast cancer	0.00395	0.00971	CbGbCtD
Cephalexin—CYP3A4—Docetaxel—breast cancer	0.00337	0.00829	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—breast cancer	0.00251	0.00618	CbGbCtD
Cephalexin—SLC47A1—nipple—breast cancer	0.000969	0.0612	CbGeAlD
Cephalexin—ALB—mammary gland—breast cancer	0.000936	0.0591	CbGeAlD
Cephalexin—SLC15A2—mammary gland—breast cancer	0.000781	0.0494	CbGeAlD
Cephalexin—SLC15A1—epithelium—breast cancer	0.000696	0.044	CbGeAlD
Cephalexin—SLC22A5—mammary gland—breast cancer	0.00068	0.0429	CbGeAlD
Cephalexin—SLC15A1—endometrium—breast cancer	0.000624	0.0394	CbGeAlD
Cephalexin—SLC47A1—endometrium—breast cancer	0.000585	0.037	CbGeAlD
Cephalexin—SLC22A5—nipple—breast cancer	0.000562	0.0355	CbGeAlD
Cephalexin—Carbenicillin—PLA2G4A—breast cancer	0.000554	0.395	CrCbGaD
Cephalexin—SLC47A1—uterus—breast cancer	0.000539	0.0341	CbGeAlD
Cephalexin—SLC47A1—pituitary gland—breast cancer	0.00053	0.0335	CbGeAlD
Cephalexin—SLC47A1—adipose tissue—breast cancer	0.000528	0.0333	CbGeAlD
Cephalexin—SLC47A1—female reproductive system—breast cancer	0.000485	0.0306	CbGeAlD
Cephalexin—SLC47A1—adrenal gland—breast cancer	0.000473	0.0299	CbGeAlD
Cephalexin—SLC47A1—female gonad—breast cancer	0.000441	0.0279	CbGeAlD
Cephalexin—SLC15A1—endocrine gland—breast cancer	0.000438	0.0276	CbGeAlD
Cephalexin—SLC47A1—endocrine gland—breast cancer	0.00041	0.0259	CbGeAlD
Cephalexin—SLC15A2—endometrium—breast cancer	0.00039	0.0246	CbGeAlD
Cephalexin—ALB—adrenal gland—breast cancer	0.000378	0.0239	CbGeAlD
Cephalexin—SLC22A5—skin of body—breast cancer	0.00036	0.0227	CbGeAlD
Cephalexin—SLC15A2—pituitary gland—breast cancer	0.000353	0.0223	CbGeAlD
Cephalexin—SLC22A5—endometrium—breast cancer	0.000339	0.0214	CbGeAlD
Cephalexin—SLC15A2—female reproductive system—breast cancer	0.000323	0.0204	CbGeAlD
Cephalexin—SLC15A2—adrenal gland—breast cancer	0.000315	0.0199	CbGeAlD
Cephalexin—SLC22A5—pituitary gland—breast cancer	0.000307	0.0194	CbGeAlD
Cephalexin—SLC22A5—adipose tissue—breast cancer	0.000306	0.0193	CbGeAlD
Cephalexin—SLC15A2—female gonad—breast cancer	0.000294	0.0186	CbGeAlD
Cephalexin—SLC47A1—lymph node—breast cancer	0.000284	0.0179	CbGeAlD
Cephalexin—SLC22A5—female reproductive system—breast cancer	0.000281	0.0178	CbGeAlD
Cephalexin—Benzylpenicillin—SLCO1B1—breast cancer	0.000279	0.199	CrCbGaD
Cephalexin—SLC22A5—adrenal gland—breast cancer	0.000274	0.0173	CbGeAlD
Cephalexin—SLC15A2—endocrine gland—breast cancer	0.000274	0.0173	CbGeAlD
Cephalexin—SLC22A5—female gonad—breast cancer	0.000256	0.0162	CbGeAlD
Cephalexin—ALB—lymph node—breast cancer	0.000227	0.0143	CbGeAlD
Cephalexin—SLC15A2—lymph node—breast cancer	0.000189	0.0119	CbGeAlD
Cephalexin—CYP3A4—female reproductive system—breast cancer	0.000184	0.0116	CbGeAlD
Cephalexin—CYP2D6—female reproductive system—breast cancer	0.000181	0.0115	CbGeAlD
Cephalexin—CYP2D6—female gonad—breast cancer	0.000165	0.0104	CbGeAlD
Cephalexin—SLC22A5—lymph node—breast cancer	0.000164	0.0104	CbGeAlD
Cephalexin—CYP3A4—endocrine gland—breast cancer	0.000156	0.00985	CbGeAlD
Cephalexin—Cefpiramide—ALB—breast cancer	0.000156	0.111	CrCbGaD
Cephalexin—CYP2D6—endocrine gland—breast cancer	0.000154	0.0097	CbGeAlD
Cephalexin—Cefonicid—ALB—breast cancer	0.000136	0.0969	CrCbGaD
Cephalexin—Cefradine—CYP3A4—breast cancer	8.8e-05	0.0628	CrCbGaD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—breast cancer	7.89e-05	0.000451	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—breast cancer	7.89e-05	0.000451	CcSEcCtD
Cephalexin—Vomiting—Vinorelbine—breast cancer	7.86e-05	0.000449	CcSEcCtD
Cephalexin—Body temperature increased—Gemcitabine—breast cancer	7.85e-05	0.000448	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—breast cancer	7.81e-05	0.000447	CcSEcCtD
Cephalexin—Dizziness—Thiotepa—breast cancer	7.8e-05	0.000446	CcSEcCtD
Cephalexin—Rash—Vinorelbine—breast cancer	7.79e-05	0.000445	CcSEcCtD
Cephalexin—Dermatitis—Vinorelbine—breast cancer	7.78e-05	0.000445	CcSEcCtD
Cephalexin—Urticaria—Fluorouracil—breast cancer	7.75e-05	0.000443	CcSEcCtD
Cephalexin—Headache—Vinorelbine—breast cancer	7.74e-05	0.000442	CcSEcCtD
Cephalexin—Leukopenia—Docetaxel—breast cancer	7.73e-05	0.000442	CcSEcCtD
Cephalexin—Body temperature increased—Fluorouracil—breast cancer	7.71e-05	0.000441	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—breast cancer	7.65e-05	0.000437	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.57e-05	0.000433	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—breast cancer	7.53e-05	0.00043	CcSEcCtD
Cephalexin—Hypersensitivity—Mitoxantrone—breast cancer	7.51e-05	0.000429	CcSEcCtD
Cephalexin—Hypersensitivity—Irinotecan—breast cancer	7.51e-05	0.000429	CcSEcCtD
Cephalexin—Vomiting—Thiotepa—breast cancer	7.5e-05	0.000429	CcSEcCtD
Cephalexin—Leukopenia—Capecitabine—breast cancer	7.48e-05	0.000427	CcSEcCtD
Cephalexin—Convulsion—Docetaxel—breast cancer	7.48e-05	0.000427	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—breast cancer	7.45e-05	0.000426	CcSEcCtD
Cephalexin—Infestation—Epirubicin—breast cancer	7.45e-05	0.000426	CcSEcCtD
Cephalexin—Rash—Thiotepa—breast cancer	7.44e-05	0.000425	CcSEcCtD
Cephalexin—Dermatitis—Thiotepa—breast cancer	7.43e-05	0.000425	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—breast cancer	7.43e-05	0.000425	CcSEcCtD
Cephalexin—Headache—Thiotepa—breast cancer	7.39e-05	0.000422	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—breast cancer	7.39e-05	0.000422	CcSEcCtD
Cephalexin—Arthralgia—Docetaxel—breast cancer	7.35e-05	0.00042	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—breast cancer	7.34e-05	0.00042	CcSEcCtD
Cephalexin—Nausea—Vinorelbine—breast cancer	7.34e-05	0.000419	CcSEcCtD
Cephalexin—Dyspepsia—Paclitaxel—breast cancer	7.32e-05	0.000418	CcSEcCtD
Cephalexin—Asthenia—Irinotecan—breast cancer	7.31e-05	0.000418	CcSEcCtD
Cephalexin—Asthenia—Mitoxantrone—breast cancer	7.31e-05	0.000418	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.3e-05	0.000417	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—breast cancer	7.23e-05	0.000413	CcSEcCtD
Cephalexin—Hypersensitivity—Fluorouracil—breast cancer	7.19e-05	0.000411	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—breast cancer	7.18e-05	0.00041	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Paclitaxel—breast cancer	7.17e-05	0.00041	CcSEcCtD
Cephalexin—Fatigue—Paclitaxel—breast cancer	7.16e-05	0.000409	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—breast cancer	7.15e-05	0.000408	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—breast cancer	7.15e-05	0.000408	CcSEcCtD
Cephalexin—Asthenia—Gemcitabine—breast cancer	7.12e-05	0.000407	CcSEcCtD
Cephalexin—Arthralgia—Capecitabine—breast cancer	7.11e-05	0.000407	CcSEcCtD
Cephalexin—Confusional state—Docetaxel—breast cancer	7.1e-05	0.000406	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.06e-05	0.000404	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—breast cancer	7.06e-05	0.000403	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—breast cancer	7.05e-05	0.000403	CcSEcCtD
Cephalexin—Anaphylactic shock—Docetaxel—breast cancer	7.04e-05	0.000403	CcSEcCtD
Cephalexin—Pruritus—Gemcitabine—breast cancer	7.02e-05	0.000401	CcSEcCtD
Cephalexin—Nausea—Thiotepa—breast cancer	7.01e-05	0.000401	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—breast cancer	7e-05	0.0004	CcSEcCtD
Cephalexin—Diarrhoea—Irinotecan—breast cancer	6.97e-05	0.000398	CcSEcCtD
Cephalexin—Diarrhoea—Mitoxantrone—breast cancer	6.97e-05	0.000398	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—breast cancer	6.95e-05	0.000397	CcSEcCtD
Cephalexin—Nervous system disorder—Docetaxel—breast cancer	6.91e-05	0.000395	CcSEcCtD
Cephalexin—Pruritus—Fluorouracil—breast cancer	6.9e-05	0.000395	CcSEcCtD
Cephalexin—Thrombocytopenia—Docetaxel—breast cancer	6.9e-05	0.000394	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—breast cancer	6.89e-05	0.000394	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—breast cancer	6.89e-05	0.000394	CcSEcCtD
Cephalexin—Confusional state—Capecitabine—breast cancer	6.88e-05	0.000393	CcSEcCtD
Cephalexin—Feeling abnormal—Paclitaxel—breast cancer	6.85e-05	0.000391	CcSEcCtD
Cephalexin—Skin disorder—Docetaxel—breast cancer	6.84e-05	0.000391	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	6.83e-05	0.000391	CcSEcCtD
Cephalexin—Ampicillin—ALB—breast cancer	6.81e-05	0.0486	CrCbGaD
Cephalexin—Gastrointestinal pain—Paclitaxel—breast cancer	6.8e-05	0.000388	CcSEcCtD
Cephalexin—Diarrhoea—Gemcitabine—breast cancer	6.79e-05	0.000388	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—breast cancer	6.76e-05	0.000386	CcSEcCtD
Cephalexin—Dizziness—Irinotecan—breast cancer	6.74e-05	0.000385	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—breast cancer	6.72e-05	0.000384	CcSEcCtD
Cephalexin—Nervous system disorder—Capecitabine—breast cancer	6.69e-05	0.000382	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—breast cancer	6.69e-05	0.000382	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—breast cancer	6.69e-05	0.000382	CcSEcCtD
Cephalexin—Diarrhoea—Fluorouracil—breast cancer	6.68e-05	0.000382	CcSEcCtD
Cephalexin—Thrombocytopenia—Capecitabine—breast cancer	6.68e-05	0.000382	CcSEcCtD
Cephalexin—Skin disorder—Capecitabine—breast cancer	6.62e-05	0.000379	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—breast cancer	6.6e-05	0.000377	CcSEcCtD
Cephalexin—Urticaria—Paclitaxel—breast cancer	6.6e-05	0.000377	CcSEcCtD
Cephalexin—Cefazolin—ALB—breast cancer	6.58e-05	0.047	CrCbGaD
Cephalexin—Connective tissue disorder—Epirubicin—breast cancer	6.57e-05	0.000376	CcSEcCtD
Cephalexin—Body temperature increased—Paclitaxel—breast cancer	6.57e-05	0.000375	CcSEcCtD
Cephalexin—Abdominal pain—Paclitaxel—breast cancer	6.57e-05	0.000375	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—breast cancer	6.56e-05	0.000375	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—breast cancer	6.52e-05	0.000373	CcSEcCtD
Cephalexin—Vomiting—Irinotecan—breast cancer	6.48e-05	0.00037	CcSEcCtD
Cephalexin—Vomiting—Mitoxantrone—breast cancer	6.48e-05	0.00037	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—breast cancer	6.45e-05	0.000369	CcSEcCtD
Cephalexin—Dizziness—Fluorouracil—breast cancer	6.45e-05	0.000369	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—breast cancer	6.43e-05	0.000368	CcSEcCtD
Cephalexin—Rash—Mitoxantrone—breast cancer	6.42e-05	0.000367	CcSEcCtD
Cephalexin—Rash—Irinotecan—breast cancer	6.42e-05	0.000367	CcSEcCtD
Cephalexin—Dermatitis—Mitoxantrone—breast cancer	6.42e-05	0.000367	CcSEcCtD
Cephalexin—Dermatitis—Irinotecan—breast cancer	6.42e-05	0.000367	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Docetaxel—breast cancer	6.42e-05	0.000367	CcSEcCtD
Cephalexin—Headache—Mitoxantrone—breast cancer	6.38e-05	0.000365	CcSEcCtD
Cephalexin—Headache—Irinotecan—breast cancer	6.38e-05	0.000365	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—breast cancer	6.32e-05	0.000361	CcSEcCtD
Cephalexin—Vomiting—Gemcitabine—breast cancer	6.31e-05	0.000361	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—breast cancer	6.26e-05	0.000358	CcSEcCtD
Cephalexin—Rash—Gemcitabine—breast cancer	6.26e-05	0.000358	CcSEcCtD
Cephalexin—Dermatitis—Gemcitabine—breast cancer	6.25e-05	0.000357	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—breast cancer	6.22e-05	0.000355	CcSEcCtD
Cephalexin—Headache—Gemcitabine—breast cancer	6.22e-05	0.000355	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Capecitabine—breast cancer	6.21e-05	0.000355	CcSEcCtD
Cephalexin—Vomiting—Fluorouracil—breast cancer	6.2e-05	0.000355	CcSEcCtD
Cephalexin—Dyspepsia—Docetaxel—breast cancer	6.2e-05	0.000354	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—breast cancer	6.19e-05	0.000354	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—breast cancer	6.19e-05	0.000354	CcSEcCtD
Cephalexin—Rash—Fluorouracil—breast cancer	6.15e-05	0.000352	CcSEcCtD
Cephalexin—Dermatitis—Fluorouracil—breast cancer	6.15e-05	0.000351	CcSEcCtD
Cephalexin—Hypersensitivity—Paclitaxel—breast cancer	6.12e-05	0.00035	CcSEcCtD
Cephalexin—Headache—Fluorouracil—breast cancer	6.11e-05	0.000349	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—breast cancer	6.11e-05	0.000349	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Docetaxel—breast cancer	6.08e-05	0.000348	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—breast cancer	6.08e-05	0.000348	CcSEcCtD
Cephalexin—Fatigue—Docetaxel—breast cancer	6.07e-05	0.000347	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—breast cancer	6.07e-05	0.000347	CcSEcCtD
Cephalexin—Nausea—Mitoxantrone—breast cancer	6.05e-05	0.000346	CcSEcCtD
Cephalexin—Nausea—Irinotecan—breast cancer	6.05e-05	0.000346	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—breast cancer	6.04e-05	0.000345	CcSEcCtD
Cephalexin—Dyspepsia—Capecitabine—breast cancer	6e-05	0.000343	CcSEcCtD
Cephalexin—Asthenia—Paclitaxel—breast cancer	5.96e-05	0.000341	CcSEcCtD
Cephalexin—Nausea—Gemcitabine—breast cancer	5.9e-05	0.000337	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Capecitabine—breast cancer	5.89e-05	0.000337	CcSEcCtD
Cephalexin—Fatigue—Capecitabine—breast cancer	5.88e-05	0.000336	CcSEcCtD
Cephalexin—Pruritus—Paclitaxel—breast cancer	5.88e-05	0.000336	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—breast cancer	5.86e-05	0.000335	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—breast cancer	5.85e-05	0.000334	CcSEcCtD
Cephalexin—Feeling abnormal—Docetaxel—breast cancer	5.8e-05	0.000332	CcSEcCtD
Cephalexin—Nausea—Fluorouracil—breast cancer	5.8e-05	0.000331	CcSEcCtD
Cephalexin—Gastrointestinal pain—Docetaxel—breast cancer	5.76e-05	0.000329	CcSEcCtD
Cephalexin—Diarrhoea—Paclitaxel—breast cancer	5.69e-05	0.000325	CcSEcCtD
Cephalexin—Feeling abnormal—Capecitabine—breast cancer	5.62e-05	0.000321	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—breast cancer	5.59e-05	0.000319	CcSEcCtD
Cephalexin—Gastrointestinal pain—Capecitabine—breast cancer	5.58e-05	0.000319	CcSEcCtD
Cephalexin—Abdominal pain—Docetaxel—breast cancer	5.57e-05	0.000318	CcSEcCtD
Cephalexin—Body temperature increased—Docetaxel—breast cancer	5.57e-05	0.000318	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—breast cancer	5.57e-05	0.000318	CcSEcCtD
Cephalexin—Dizziness—Paclitaxel—breast cancer	5.5e-05	0.000314	CcSEcCtD
Cephalexin—Cefalotin—ALB—breast cancer	5.46e-05	0.039	CrCbGaD
Cephalexin—Mental disorder—Doxorubicin—breast cancer	5.42e-05	0.00031	CcSEcCtD
Cephalexin—Urticaria—Capecitabine—breast cancer	5.42e-05	0.00031	CcSEcCtD
Cephalexin—Abdominal pain—Capecitabine—breast cancer	5.39e-05	0.000308	CcSEcCtD
Cephalexin—Body temperature increased—Capecitabine—breast cancer	5.39e-05	0.000308	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—breast cancer	5.39e-05	0.000308	CcSEcCtD
Cephalexin—Agitation—Epirubicin—breast cancer	5.35e-05	0.000306	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—breast cancer	5.3e-05	0.000303	CcSEcCtD
Cephalexin—Vomiting—Paclitaxel—breast cancer	5.28e-05	0.000302	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.26e-05	0.000301	CcSEcCtD
Cephalexin—Rash—Paclitaxel—breast cancer	5.24e-05	0.000299	CcSEcCtD
Cephalexin—Dermatitis—Paclitaxel—breast cancer	5.23e-05	0.000299	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—breast cancer	5.21e-05	0.000298	CcSEcCtD
Cephalexin—Headache—Paclitaxel—breast cancer	5.21e-05	0.000298	CcSEcCtD
Cephalexin—Hypersensitivity—Docetaxel—breast cancer	5.19e-05	0.000297	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—breast cancer	5.12e-05	0.000293	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—breast cancer	5.08e-05	0.00029	CcSEcCtD
Cephalexin—Asthenia—Docetaxel—breast cancer	5.05e-05	0.000289	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—breast cancer	5.04e-05	0.000288	CcSEcCtD
Cephalexin—Hypersensitivity—Capecitabine—breast cancer	5.02e-05	0.000287	CcSEcCtD
Cephalexin—Pruritus—Docetaxel—breast cancer	4.98e-05	0.000285	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—breast cancer	4.98e-05	0.000285	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—breast cancer	4.97e-05	0.000284	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—breast cancer	4.96e-05	0.000283	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—breast cancer	4.95e-05	0.000283	CcSEcCtD
Cephalexin—Nausea—Paclitaxel—breast cancer	4.94e-05	0.000282	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—breast cancer	4.93e-05	0.000282	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.92e-05	0.000281	CcSEcCtD
Cephalexin—Asthenia—Capecitabine—breast cancer	4.89e-05	0.00028	CcSEcCtD
Cephalexin—Pruritus—Capecitabine—breast cancer	4.82e-05	0.000276	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—breast cancer	4.82e-05	0.000276	CcSEcCtD
Cephalexin—Diarrhoea—Docetaxel—breast cancer	4.82e-05	0.000275	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—breast cancer	4.79e-05	0.000274	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—breast cancer	4.75e-05	0.000272	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—breast cancer	4.67e-05	0.000267	CcSEcCtD
Cephalexin—Diarrhoea—Capecitabine—breast cancer	4.67e-05	0.000267	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—breast cancer	4.66e-05	0.000266	CcSEcCtD
Cephalexin—Dizziness—Docetaxel—breast cancer	4.66e-05	0.000266	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—breast cancer	4.65e-05	0.000266	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—breast cancer	4.63e-05	0.000264	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—breast cancer	4.61e-05	0.000264	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—breast cancer	4.59e-05	0.000262	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.55e-05	0.00026	CcSEcCtD
Cephalexin—Dizziness—Capecitabine—breast cancer	4.51e-05	0.000258	CcSEcCtD
Cephalexin—Vomiting—Docetaxel—breast cancer	4.48e-05	0.000256	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—breast cancer	4.47e-05	0.000255	CcSEcCtD
Cephalexin—Rash—Docetaxel—breast cancer	4.44e-05	0.000254	CcSEcCtD
Cephalexin—Dermatitis—Docetaxel—breast cancer	4.44e-05	0.000254	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—breast cancer	4.43e-05	0.000253	CcSEcCtD
Cephalexin—Headache—Docetaxel—breast cancer	4.41e-05	0.000252	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—breast cancer	4.4e-05	0.000251	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—breast cancer	4.38e-05	0.000251	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—breast cancer	4.38e-05	0.00025	CcSEcCtD
Cephalexin—Vomiting—Capecitabine—breast cancer	4.34e-05	0.000248	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—breast cancer	4.33e-05	0.000247	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—breast cancer	4.31e-05	0.000246	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—breast cancer	4.3e-05	0.000246	CcSEcCtD
Cephalexin—Rash—Capecitabine—breast cancer	4.3e-05	0.000246	CcSEcCtD
Cephalexin—Dermatitis—Capecitabine—breast cancer	4.3e-05	0.000246	CcSEcCtD
Cephalexin—Headache—Capecitabine—breast cancer	4.27e-05	0.000244	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—breast cancer	4.27e-05	0.000244	CcSEcCtD
Cephalexin—Nausea—Docetaxel—breast cancer	4.18e-05	0.000239	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—breast cancer	4.18e-05	0.000239	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—breast cancer	4.18e-05	0.000239	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—breast cancer	4.15e-05	0.000237	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—breast cancer	4.1e-05	0.000234	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—breast cancer	4.1e-05	0.000234	CcSEcCtD
Cephalexin—Nausea—Capecitabine—breast cancer	4.05e-05	0.000232	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—breast cancer	4.03e-05	0.000231	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—breast cancer	4.01e-05	0.000229	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—breast cancer	4.01e-05	0.000229	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.01e-05	0.000229	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—breast cancer	3.92e-05	0.000224	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—breast cancer	3.88e-05	0.000222	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—breast cancer	3.87e-05	0.000221	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—breast cancer	3.8e-05	0.000217	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—breast cancer	3.79e-05	0.000217	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—breast cancer	3.77e-05	0.000216	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—breast cancer	3.76e-05	0.000215	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—breast cancer	3.76e-05	0.000215	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—breast cancer	3.74e-05	0.000214	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—breast cancer	3.64e-05	0.000208	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—breast cancer	3.62e-05	0.000207	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—breast cancer	3.59e-05	0.000205	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—breast cancer	3.59e-05	0.000205	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—breast cancer	3.5e-05	0.0002	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—breast cancer	3.49e-05	0.0002	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—breast cancer	3.48e-05	0.000199	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—breast cancer	3.48e-05	0.000199	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—breast cancer	3.47e-05	0.000199	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—breast cancer	3.41e-05	0.000195	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—breast cancer	3.36e-05	0.000192	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—breast cancer	3.36e-05	0.000192	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—breast cancer	3.25e-05	0.000186	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—breast cancer	3.24e-05	0.000185	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—breast cancer	3.23e-05	0.000184	CcSEcCtD
Cephalexin—Rash—Methotrexate—breast cancer	3.2e-05	0.000183	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—breast cancer	3.2e-05	0.000183	CcSEcCtD
Cephalexin—Headache—Methotrexate—breast cancer	3.18e-05	0.000182	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—breast cancer	3.15e-05	0.00018	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—breast cancer	3.14e-05	0.00018	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—breast cancer	3.11e-05	0.000178	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—breast cancer	3.02e-05	0.000173	CcSEcCtD
Cephalexin—Nausea—Methotrexate—breast cancer	3.02e-05	0.000172	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—breast cancer	3.01e-05	0.000172	CcSEcCtD
Cephalexin—Rash—Epirubicin—breast cancer	3e-05	0.000171	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—breast cancer	2.99e-05	0.000171	CcSEcCtD
Cephalexin—Headache—Epirubicin—breast cancer	2.98e-05	0.00017	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—breast cancer	2.91e-05	0.000166	CcSEcCtD
Cephalexin—Nausea—Epirubicin—breast cancer	2.82e-05	0.000161	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—breast cancer	2.8e-05	0.00016	CcSEcCtD
Cephalexin—Rash—Doxorubicin—breast cancer	2.77e-05	0.000158	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—breast cancer	2.77e-05	0.000158	CcSEcCtD
Cephalexin—Headache—Doxorubicin—breast cancer	2.75e-05	0.000157	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—breast cancer	2.61e-05	0.000149	CcSEcCtD
Cephalexin—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	8.73e-06	0.000141	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA2—breast cancer	8.72e-06	0.000141	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPX2—breast cancer	8.72e-06	0.000141	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PHGDH—breast cancer	8.69e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UMPS—breast cancer	8.69e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—FHL2—breast cancer	8.69e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ADSL—breast cancer	8.69e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NME1—breast cancer	8.69e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CHST9—breast cancer	8.65e-06	0.000139	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MMP1—breast cancer	8.62e-06	0.000139	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPX4—breast cancer	8.62e-06	0.000139	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SULT1A1—breast cancer	8.62e-06	0.000139	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—BRIP1—breast cancer	8.52e-06	0.000137	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LDHB—breast cancer	8.52e-06	0.000137	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HPSE—breast cancer	8.52e-06	0.000137	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAU—breast cancer	8.46e-06	0.000136	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CDK2—breast cancer	8.46e-06	0.000136	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA1—breast cancer	8.42e-06	0.000136	CbGpPWpGaD
Cephalexin—ALB—Metabolism—IDH1—breast cancer	8.42e-06	0.000136	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAT2—breast cancer	8.32e-06	0.000134	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CAV1—breast cancer	8.26e-06	0.000133	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	8.26e-06	0.000133	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—COX11—breast cancer	8.2e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCC1—breast cancer	8.08e-06	0.00013	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA3—breast cancer	8.08e-06	0.00013	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMMR—breast cancer	8.08e-06	0.00013	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	8.02e-06	0.000129	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—FN1—breast cancer	7.87e-06	0.000127	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARGC1B—breast cancer	7.83e-06	0.000126	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS2—breast cancer	7.77e-06	0.000125	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CG—breast cancer	7.53e-06	0.000121	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.52e-06	0.000121	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CDA—breast cancer	7.5e-06	0.000121	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SHMT1—breast cancer	7.5e-06	0.000121	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—EGF—breast cancer	7.44e-06	0.00012	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA4—breast cancer	7.39e-06	0.000119	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CA9—breast cancer	7.39e-06	0.000119	CbGpPWpGaD
Cephalexin—ALB—Metabolism—DPYD—breast cancer	7.3e-06	0.000118	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MED12—breast cancer	7.3e-06	0.000118	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.22e-06	0.000116	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC2A5—breast cancer	7.22e-06	0.000116	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA2—breast cancer	7.2e-06	0.000116	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPX2—breast cancer	7.2e-06	0.000116	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALDOA—breast cancer	7.18e-06	0.000116	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPX4—breast cancer	7.11e-06	0.000115	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SULT1A1—breast cancer	7.11e-06	0.000115	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA3—breast cancer	6.97e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APRT—breast cancer	6.97e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—IDH1—breast cancer	6.95e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA1—breast cancer	6.95e-06	0.000112	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC2A2—breast cancer	6.92e-06	0.000112	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF1—breast cancer	6.89e-06	0.000111	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT2—breast cancer	6.89e-06	0.000111	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAT2—breast cancer	6.87e-06	0.000111	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.85e-06	0.00011	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	6.82e-06	0.00011	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTR—breast cancer	6.78e-06	0.000109	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CPT1A—breast cancer	6.78e-06	0.000109	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCG2—breast cancer	6.78e-06	0.000109	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HPGDS—breast cancer	6.65e-06	0.000107	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CD—breast cancer	6.62e-06	0.000107	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HBA1—breast cancer	6.61e-06	0.000106	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ESRRA—breast cancer	6.55e-06	0.000106	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.55e-06	0.000106	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE1—breast cancer	6.54e-06	0.000105	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ACHE—breast cancer	6.45e-06	0.000104	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTT1—breast cancer	6.45e-06	0.000104	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS3—breast cancer	6.25e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPI—breast cancer	6.21e-06	0.0001	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HADHB—breast cancer	6.21e-06	0.0001	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP17A1—breast cancer	6.11e-06	9.84e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ENO1—breast cancer	6.05e-06	9.74e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTGS1—breast cancer	6.05e-06	9.74e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—DPYD—breast cancer	6.02e-06	9.7e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MED12—breast cancer	6.02e-06	9.7e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.02e-06	9.7e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALDOA—breast cancer	5.93e-06	9.55e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2D6—breast cancer	5.93e-06	9.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.93e-06	9.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.93e-06	9.55e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—RAF1—breast cancer	5.91e-06	9.52e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA2—breast cancer	5.82e-06	9.38e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CB—breast cancer	5.77e-06	9.29e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA3—breast cancer	5.76e-06	9.27e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC2A2—breast cancer	5.72e-06	9.21e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UMPS—breast cancer	5.68e-06	9.15e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PHGDH—breast cancer	5.68e-06	9.15e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—FHL2—breast cancer	5.68e-06	9.15e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ADSL—breast cancer	5.68e-06	9.15e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NME1—breast cancer	5.68e-06	9.15e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—FASN—breast cancer	5.64e-06	9.09e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—BCHE—breast cancer	5.62e-06	9.05e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCG2—breast cancer	5.6e-06	9.02e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CPT1A—breast cancer	5.6e-06	9.02e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTR—breast cancer	5.6e-06	9.02e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LDHB—breast cancer	5.57e-06	8.98e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—BRIP1—breast cancer	5.57e-06	8.98e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HPSE—breast cancer	5.57e-06	8.98e-05	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	5.57e-06	8.98e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC5A5—breast cancer	5.55e-06	8.94e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HPGDS—breast cancer	5.49e-06	8.85e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HBA1—breast cancer	5.46e-06	8.79e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NQO1—breast cancer	5.36e-06	8.64e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC2A1—breast cancer	5.36e-06	8.64e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTT1—breast cancer	5.33e-06	8.58e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ACHE—breast cancer	5.33e-06	8.58e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2—breast cancer	5.3e-06	8.53e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA3—breast cancer	5.28e-06	8.51e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCC1—breast cancer	5.28e-06	8.51e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMMR—breast cancer	5.28e-06	8.51e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.25e-06	8.46e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP3A4—breast cancer	5.23e-06	8.42e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.2e-06	8.38e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1B1—breast cancer	5.14e-06	8.28e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.12e-06	8.24e-05	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	5.11e-06	8.24e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP17A1—breast cancer	5.04e-06	8.12e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HSP90AA1—breast cancer	5.04e-06	8.12e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ENO1—breast cancer	4.99e-06	8.04e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTGS1—breast cancer	4.99e-06	8.04e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA1—breast cancer	4.9e-06	7.9e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—STK11—breast cancer	4.83e-06	7.79e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP19A1—breast cancer	4.83e-06	7.79e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA4—breast cancer	4.83e-06	7.78e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CA9—breast cancer	4.83e-06	7.78e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA2—breast cancer	4.81e-06	7.74e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA2—breast cancer	4.71e-06	7.59e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPX2—breast cancer	4.71e-06	7.59e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—FASN—breast cancer	4.66e-06	7.51e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SULT1A1—breast cancer	4.65e-06	7.49e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPX4—breast cancer	4.65e-06	7.49e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—BCHE—breast cancer	4.64e-06	7.48e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SRC—breast cancer	4.62e-06	7.45e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC5A5—breast cancer	4.58e-06	7.38e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—IDH1—breast cancer	4.54e-06	7.32e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA1—breast cancer	4.54e-06	7.32e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.54e-06	7.31e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—breast cancer	4.5e-06	7.25e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—COMT—breast cancer	4.49e-06	7.24e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAT2—breast cancer	4.49e-06	7.24e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTP1—breast cancer	4.47e-06	7.2e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC2A1—breast cancer	4.43e-06	7.13e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NQO1—breast cancer	4.43e-06	7.13e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMOX1—breast cancer	4.41e-06	7.11e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ITPR1—breast cancer	4.4e-06	7.09e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP3A4—breast cancer	4.32e-06	6.96e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MAPK3—breast cancer	4.26e-06	6.86e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1B1—breast cancer	4.24e-06	6.84e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCB1—breast cancer	4.23e-06	6.82e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.16e-06	6.71e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TYMS—breast cancer	4.16e-06	6.7e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—breast cancer	4.13e-06	6.66e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—breast cancer	4.11e-06	6.62e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOR1—breast cancer	4.11e-06	6.62e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PLA2G4A—breast cancer	4.11e-06	6.62e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA1—breast cancer	4.05e-06	6.52e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—STK11—breast cancer	3.99e-06	6.43e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP19A1—breast cancer	3.99e-06	6.43e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MED12—breast cancer	3.94e-06	6.35e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—DPYD—breast cancer	3.94e-06	6.35e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPX1—breast cancer	3.94e-06	6.34e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1A1—breast cancer	3.9e-06	6.28e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALDOA—breast cancer	3.88e-06	6.25e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ERCC2—breast cancer	3.86e-06	6.22e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—KRAS—breast cancer	3.83e-06	6.16e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA3—breast cancer	3.76e-06	6.06e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC2A2—breast cancer	3.74e-06	6.02e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—COMT—breast cancer	3.71e-06	5.98e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTP1—breast cancer	3.69e-06	5.95e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCG2—breast cancer	3.66e-06	5.9e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CPT1A—breast cancer	3.66e-06	5.9e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTR—breast cancer	3.66e-06	5.9e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMOX1—breast cancer	3.64e-06	5.87e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ITPR1—breast cancer	3.63e-06	5.85e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—breast cancer	3.63e-06	5.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HPGDS—breast cancer	3.59e-06	5.78e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HBA1—breast cancer	3.57e-06	5.75e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CA—breast cancer	3.52e-06	5.66e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCB1—breast cancer	3.5e-06	5.63e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTT1—breast cancer	3.48e-06	5.61e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ACHE—breast cancer	3.48e-06	5.61e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TYMS—breast cancer	3.43e-06	5.53e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TP53—breast cancer	3.4e-06	5.48e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—breast cancer	3.39e-06	5.47e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOR1—breast cancer	3.39e-06	5.47e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.39e-06	5.47e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CAV1—breast cancer	3.35e-06	5.4e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP17A1—breast cancer	3.3e-06	5.31e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ENO1—breast cancer	3.26e-06	5.26e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGS1—breast cancer	3.26e-06	5.26e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HRAS—breast cancer	3.25e-06	5.24e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPX1—breast cancer	3.25e-06	5.23e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1A1—breast cancer	3.22e-06	5.18e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.2e-06	5.16e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2D6—breast cancer	3.2e-06	5.16e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ERCC2—breast cancer	3.19e-06	5.14e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA2—breast cancer	3.14e-06	5.06e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CG—breast cancer	3.05e-06	4.92e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—FASN—breast cancer	3.05e-06	4.91e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—BCHE—breast cancer	3.03e-06	4.89e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—breast cancer	3e-06	4.83e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC5A5—breast cancer	3e-06	4.83e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NQO1—breast cancer	2.89e-06	4.66e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC2A1—breast cancer	2.89e-06	4.66e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT1—breast cancer	2.87e-06	4.63e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1B1—breast cancer	2.78e-06	4.47e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CAV1—breast cancer	2.77e-06	4.46e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.72e-06	4.38e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CD—breast cancer	2.68e-06	4.32e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA1—breast cancer	2.65e-06	4.26e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP19A1—breast cancer	2.61e-06	4.2e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—STK11—breast cancer	2.61e-06	4.2e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NOS3—breast cancer	2.53e-06	4.08e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CG—breast cancer	2.52e-06	4.06e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—COMT—breast cancer	2.43e-06	3.91e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTP1—breast cancer	2.41e-06	3.89e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMOX1—breast cancer	2.38e-06	3.84e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ITPR1—breast cancer	2.38e-06	3.83e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CB—breast cancer	2.34e-06	3.77e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTGS2—breast cancer	2.32e-06	3.73e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCB1—breast cancer	2.29e-06	3.68e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TYMS—breast cancer	2.24e-06	3.62e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOR1—breast cancer	2.22e-06	3.57e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—breast cancer	2.22e-06	3.57e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.22e-06	3.57e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CD—breast cancer	2.22e-06	3.57e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—breast cancer	2.19e-06	3.52e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPX1—breast cancer	2.12e-06	3.42e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1A1—breast cancer	2.1e-06	3.39e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NOS3—breast cancer	2.09e-06	3.37e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ERCC2—breast cancer	2.09e-06	3.36e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTEN—breast cancer	2.02e-06	3.25e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—breast cancer	1.96e-06	3.16e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CB—breast cancer	1.93e-06	3.11e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTGS2—breast cancer	1.91e-06	3.08e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CAV1—breast cancer	1.81e-06	2.91e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTEN—breast cancer	1.67e-06	2.69e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CG—breast cancer	1.65e-06	2.65e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CD—breast cancer	1.45e-06	2.33e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—breast cancer	1.43e-06	2.3e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CA—breast cancer	1.43e-06	2.3e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NOS3—breast cancer	1.37e-06	2.2e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.26e-06	2.03e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGS2—breast cancer	1.25e-06	2.01e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CA—breast cancer	1.18e-06	1.9e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKT1—breast cancer	1.16e-06	1.88e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTEN—breast cancer	1.09e-06	1.76e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKT1—breast cancer	9.61e-07	1.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CA—breast cancer	7.7e-07	1.24e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKT1—breast cancer	6.29e-07	1.01e-05	CbGpPWpGaD
